Effectiveness of Percutaneous Lumbar Epidural Adhesiolysis and Neurolysis on Low Back Pain
Low Back Pain

About this trial
This is an interventional treatment trial for Low Back Pain focused on measuring post-lumbar surgery syndrome, percutaneous lumbar epidural adhesiolysis, hypertonic saline neurolysis
Eligibility Criteria
Inclusion Criteria: Over 18 years of age History of chronic, function limiting low back pain of at least 6 months in duration Able to give voluntary, written informed consent Able to understand investigational procedures and willing to return for follow-ups No recent surgical procedures within last 3 months Exclusion Criteria: Large contained or sequestered herniation Cauda Equina symptoms and/or compressive radiculopathy Narcotic use of no greater than 100mg/day Hydrocodone, 60mg Methadone, or 100mg Morphine Uncontrolled major depression or psychiatric disorder Uncontrolled or acute medical illness Chronic sever conditions that could interfere with outcome assessments Women who are pregnant or lactating Subjects who have participated in a clinical study with an investigational product within 30 days of enrollment
Sites / Locations
- Ambulatory Surgery Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Caudal epidural injection
Percutaneous adhesiolysis
Caudal epidural with placement of catheter in sacral canal with injection of 5 mL of 2% preservative-free lidocaine, followed by 6 mL of 0.9% sodium chloride solution and 6 mg of non-particulate Betamethasone and 1 mL of sodium chloride solution
Pecutaneous adhesiolysis and targeted placement of Racz catheter with injection of 5 mL of 2% preservative-free lidocaine, followed by 6 mL of 10% sodium chloride solution and 6 mg of non-particulate Betamethasone and 1 mL of sodium chloride solution